Open Accessp16/CDKN2 Gene and p53 Gene Alterations in Japanese Non‐smoking Female Lung Adenocarcinoma
Author(s) -
Takeshima Yukio,
Nishisaka Takashi,
Kawano Ryoji,
Kishizuchi Kentaro,
Fujii Satoshi,
Kitaguchi Souichi,
Inai Kouki
Publication year - 1996
Publication title -
japanese journal of cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 0910-5050
DOI - 10.1111/j.1349-7006.1996.tb03150.x
Subject(s) - loss of heterozygosity , tumor suppressor gene , point mutation , adenocarcinoma , biology , lung , lung cancer , gene , germline mutation , cancer research , gene mutation , mutation , pathology , somatic cell , immunohistochemistry , carcinogenesis , genetics , cancer , medicine , immunology , allele
Primary lung adenocarcinomas in non‐smoking females are increasing in the USA and Japan. Environmental factors such as passive smoking, asbestos, domestic radon, and hormonal effects have been implicated, but the etiology is still uncertain. We therefore analyzed point mutations of p16 gene, a newly characterized tumor suppressor gene, and compared the results with alterations of p53 gene in 28 primary lung adenocarcinomas in non‐smoking Japanese females. There were no cases with somatic point mutation of p16 gene, except for one case with two germline mutations (silent mutations). In contrast, six out of 16 informative cases showed loss of heterozygosity of p53 gene using a TP53 microsatellite marker and 19 out of 28 cases showed expression of oncoprotein using DO‐7 immunohistochemistry. These findings suggest that p16 gene alteration is a rare event in primary lung adenocarcinomas in Japanese non‐smoking females, compared with alterations of the p53 gene.